Straumann Holding AG (Straumann) is a manufacturer and supplier of dental implants, instruments, biomaterials, CAD/ CAM prosthetics, and digital solutions for use in tooth replacement and restoration of tooth or prevention of tooth loss; and training and support services. The company serves general dentists, prosthodontists, oral surgeons, periodontists, orthodontists, dental technicians and laboratories, and corporate customers including distributors, dental chains, hospitals, and university clinics.

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.

Straumann Holding AG (Straumann) formed the Implantology Business Unit with a focus on driving disruptive innovation in implantology and combining research and development activities with marketing. The initiative allows the company to utilize its full potential of multi-brand implant strategy, increase its efficiency, focus on customer obsession, and accelerate the speed of innovation. The company partners with universities, clinics, research institutes, networks, and communities to enhance the services to its patients. It has academic collaborations such as International Team for Implantology (ITI) and the Latin American Institute of Dental Research and Education to provide training and education to dental professionals. The company has more than 1452 active patents in which 111 patents granted in FY2023. It operates with 10 brands across and over 20 solutions launched in FY2023. Straumann invests in dynamic surgical navigation which is the future in the digitalization of dental surgery. In FY2023, the company spent CHF111.1 million on R&D, which as a percentage of revenue stood at 4.6%.